# Guangzhou Huanye Pharmaceutical Co., Ltd. · 66-66 · CHINA — FDA import alert red lists: firms subject to detention without physical examination For Guangzhou Huanye Pharmaceutical Co., Ltd. · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Methscopolamine Nitrate | Methscopolamine Nitrate; product code is 61 K - - 99 Anti-Cholinergic, N.E.C. | 66 B - - 99 Stimulant N.E.C; date published is 10/20/2009; address is 195 Fangcun Dadao E , Guangzhou, Yandong CHINA, verified against its source on 2026-09-16. - **Firm:** Guangzhou Huanye Pharmaceutical Co., Ltd. _(verified: appears in the quote below)_ - **Import alert:** 66-66 - **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122" - **Country:** CHINA _(verified: appears in the quote below)_ - **Address:** 195 Fangcun Dadao E , Guangzhou, Yandong CHINA _(verified: appears in the quote below)_ - **Date published:** 10/20/2009 _(verified: appears in the quote below)_ - **Product code:** 61 K - - 99 Anti-Cholinergic, N.E.C. | 66 B - - 99 Stimulant N.E.C. _(verified: each item appears in the quote below)_ - **Product:** Methscopolamine Nitrate | Methscopolamine Nitrate _(verified: each item appears in the quote below)_ ## What the source says > Guangzhou Huanye Pharmaceutical Co., Ltd. Date Published : 10/20/2009 195 Fangcun Dadao E , Guangzhou, Yandong CHINA 61 K - - 99 Anti-Cholinergic, N.E.C. Date Published: 10/20/2009 Desc: Methscopolamine Nitrate 66 B - - 99 Stimulant N.E.C. Date Published: 10/20/2009 Desc: Methscopolamine Nitrate ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_202.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).